10 Abubuwa da Ya kamata Ka San Game da Hyaluronan
Harkokin hyaluronan ne wani zaɓi don maganin osteoarthritis na gwiwa . Osteoarthritis wani cuta ne wanda ke dauke da cututtuka wadda ke da alamun rinjayar guringuntsi. Ƙarshen ƙasusuwan biyu a cikin haɗin haɗin kai an rufe shi da guringuntsi, yana barin kasusuwa suyi juna da juna. Guringuntsi ma yana aiki ne a matsayin mai haɗari.
A cikin osteoarthritis , kamar yadda guringuntsi ke cirewa, canjin yanayi na canzawa kuma ya rasa ikonsa don saɗa haɗin gwiwa.
Raunin zuciya, haushi, da iyakacin iyakar motsi ga mahaɗin da aka haɗaka shine sakamakon lalacewa. Harkar da ke dauke da hyaluronan a cikin gwiwa, wanda ake kira viscosuplationation, shine kokarin inganta lubrication na gwiwa, rage ciwo, da kuma inganta yanayin kewayawa. A nan ne abubuwa 10 da ya kamata ku sani game da injections na hyaluronan.
1 - Akwai nau'in hyaluronates guda biyar da Cibiyar Abinci da Drug ta Amurka ta amince.
Anyi amfani da injections hyaluronan magani ko hanyoyin shan magani maimakon kwayoyi. An yi nazari kan tsarin osteoarthritis tun daga shekarun 1970s. A shekara ta 1997, FDA ta amince da su guda biyu da suka hada da hyaluronates guda biyu kuma sun amince da FDA guda uku. Jerin samfurin hyaluronan samuwa ya biyo tare da yardawarsu kwanakin:
- Hyalgan - Mayu 28, 1997
- Synvisc - Agusta 8, 1997
- Supartz - Janairu 24, 2001
- Orthovisc - Fabrairu 5, 2004
- Euflexxa - Disamba 3, 2004
- Synvisc-One - Fabrairu 26, 2009
2 - Hyaluronan mafi yawanci ba jimillar farko ba ne ga gwiwa osteoarthritis.
Yawancin lokaci, hawan hyaluronan (wanda wani lokaci ake kira viscosupplements) ana bada shawarar ga marasa lafiya wanda basu sami isasshen abincin jinƙai daga ƙarin magunguna masu ra'ayin mazan jiya:
- Aiki / Jiki Farko
- Rashin hasara idan haƙuri yana da nauyi
- Heat da sanyi
- Matakan kayan motsa jiki (misali, cane)
Kodayake ana amfani da injections a hyaluronan kafin a gwada wasu zaɓuɓɓukan magani , sakamakon mafi kyau yakan kasance idan mai haƙuri ya kasance a farkon matakan osteoarthritis. Magunguna a cikin ƙananan ƙarancin osteoarthritis, wadanda suke jiran jiran aiki na maye gurbin gwiwa , ana daukar su masu kyau ga 'yan takarar hyaluronan don haka suna fatan za su iya samun taimako yayin jiran.
3 - Tsarin magani don nau'i biyar na hyaluronan injections ya bambanta.
Hanyar magani tare da Synvisc, Orthovisc , ko Euflexxa na buƙatar injections daban-daban guda uku da aka ba su daya mako. Dukansu Hyalgan da Supartz suna buƙatar guda biyar masu rarraba da aka ba su daya mako. Samun injections an ba da likita ko likita a cikin ofishin su. Kusal ɗaya ko biyu za a iya allurarsa a lokaci guda. Bugu da ƙari na Synvisc-Ɗaya zuwa rubutun roka a shekara ta 2009 ya sanya injections mafi dacewa, yana buƙatar guda ɗaya maimakon nau'in injections.
4 - Yayinda aka yi muhawarar aikin da aka yi wa hyaluronan.
Nazarin na asibitoci sun kammala cewa jarabawar hyaluronan zai iya rage ciwo da inganta aikin a cikin marasa lafiya tare da tsinkayyar osteoarthritis mai sauƙi a matsakaici.
Yayinda wasu masu sukar sunyi la'akari da wannan ƙaddamarwa kuma sun ba da shawarar cewa binciken bai kasance ba a wata hanya, wasu likitoci sun gaskata babu wata hujja mai mahimmanci ko yaduwar maganin hyaluronan ya fi tasiri fiye da corticosteroid injections ko magungunan magunguna . Babu wani shaida da ke nuna cewa injections na hyaluronan yana shafar yanayin rashin lafiya. A bayyane yake cewa injections ba magani bane.
5 - Daga cikin marasa lafiya wadanda aka taimakawa ta hanyar hyaluronan injections, lokacin da taimako na jin zafi ya kasance mai sauƙi.
Abinda ya fi mahimmanci na jin zafi ya faru a makonni takwas zuwa 12 bayan daji na farko don yawancin marasa lafiya. Nazarin sun nuna cewa Synvisc da Hyalgan suna ba da taimako na jin zafi daga gwiwar osteoarthritis har zuwa watanni shida, tare da wasu marasa lafiya suna neman jin dadi har tsawon lokaci.
An nuna Supartz a cikin nazarin don bayar da taimako na jin zafi har zuwa 4 1/2 watanni bayan da aka yi na biyar.
Marasa lafiya za su iya sake maimaita hanya na jiyya tare da injections na hyaluronan. Alal misali, mai haƙuri wanda ya shafe watanni shida na taimako mai zafi daga Synvisc amma yana da ciwon jinƙai na iya kasancewa dan takara don wata hanya ta Synvisc.
6 - Don rage girman halayen illa, bayan da marasa lafiya suka kamata su guje wa ayyuka masu tsanani ga sa'o'i 48.
Sakamakon sakamako mafi rinjaye a kusa da haɗin gwiwa da aka ƙulla, wanda yawancin sauƙi ne, sun haɗa da:
- injin jin dadi na wucin gadi
- kumburi
- redness da zafi
- itching
- ragi
7 - Jigilar maganin hyaluronan kawai FDA ne kawai aka yarda don osteoarthritis na gwiwa.
Wata rana, ana iya amfani da viscosupationation don bi da sauran gidajen da shafi osteoarthritis ya shafa. Anyi amfani da ingancin hyaluronan don kafar, hip, da idon kafa.
8 - Masu haƙuri ba su daina dakatar da sauran magunguna da suke ɗauka lokacin samun injections na hyaluronan.
Ya kamata kada a yi hulɗa tare da wasu magunguna masu shan magani ko magungunan ƙwayoyin cuta masu shan ƙwayar cuta wanda mai haƙuri yana shan.
9 - Asibiti na Medicare da kamfanoni masu zaman kansu sun biya kudaden na'urorin kiwon lafiya da kuma hanyoyin da ake ganin sun dace.
A halin yanzu, Medicare zai rufe nauyin hyaluronan don gwiwa kawai. Medicare ma yana buƙatar shaidar rayayyun x-ray na gwiwa osteoarthritis. Medicare zai rufe nauyin hyaluronan kawai idan aka ba shi da jimawa fiye da kowane watanni shida. Asibiti na sirri na iya samun dokoki dabam daban don haka yana da mafi kyawun dubawa. Koyaushe duba don sabunta lafiyar Medicare.
10 - Akwai muhimman dalilai na tsaro don la'akari kafin amfani da injections hyaluronan.
Magunguna suna so su gwada Synvisc, wadanda ke rashin lafiyar kayan tsuntsaye (watau gashinsa, qwai ko kaji), suyi magana da likita. Magunguna ya kamata su sa likita su san kafafu wadanda suke kumbura ko kamuwa. Har ila yau, ba a jarraba jita-jitar hyaluronan a cikin yara ba, mata masu juna biyu, ko iyayen mata.
Sources:
Mene Ne Cikakken Ƙaƙa? Cleveland Clinic. 7/28/2007.
http://www.clevelandclinic.org/health/health-info/docs/3300/3363.asp?index=11428
Shawarwari don Magungunan Kula da lafiyar Osteoarthritis na Hip da Knee. Kwalejin Amirka na Rheumatology. 7/26/2007.
http://www.rheumatology.org/publications/guidelines/oa-mgmt.asp?aud=mem